Overview

An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

Status:
Completed

Trial end date:
2014-07-01

Target enrollment:

Participant gender:

Summary

Assess efficacy and safety of topical MOB015B, applied daily during 48 weeks, in adults with fungal nail infection.

Phase:

Phase 2

Details

Lead Sponsor:

Moberg Pharma AB